These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32167628)

  • 61. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Opioid use by patients in an orthopedics spine clinic.
    Mahowald ML; Singh JA; Majeski P
    Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
    Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A
    PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence of constipation associated with long-acting opioid therapy: a comparative study.
    Staats PS; Markowitz J; Schein J
    South Med J; 2004 Feb; 97(2):129-34. PubMed ID: 14982259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?
    Skurtveit S; Furu K; Borchgrevink P; Handal M; Fredheim O
    Pain; 2011 Jul; 152(7):1555-1561. PubMed ID: 21450405
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Side effects from opioids used for acute pain after emergency department discharge.
    Daoust R; Paquet J; Cournoyer A; Piette É; Morris J; Lessard J; Castonguay V; Williamson D; Chauny JM
    Am J Emerg Med; 2020 Apr; 38(4):695-701. PubMed ID: 31182367
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Megarectum.
    Verduron A; Devroede G; Bouchoucha M; Arhan P; Schang JC; Poisson J; Hémond M; Hébert M
    Dig Dis Sci; 1988 Sep; 33(9):1164-74. PubMed ID: 3409803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Withdrawal symptoms predict prescription opioid dependence in chronic pain patients.
    Coloma-Carmona A; Carballo JL; Rodríguez-Marín J; Pérez-Carbonell A
    Drug Alcohol Depend; 2019 Feb; 195():27-32. PubMed ID: 30562677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
    Ueberall MA; Müller-Lissner S; Buschmann-Kramm C; Bosse B
    J Int Med Res; 2011; 39(1):41-50. PubMed ID: 21672306
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
    Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
    J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-resolution Anorectal Manometry for Identifying Defecatory Disorders and Rectal Structural Abnormalities in Women.
    Prichard DO; Lee T; Parthasarathy G; Fletcher JG; Zinsmeister AR; Bharucha AE
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):412-420. PubMed ID: 27720913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Baseline severe constipation negatively impacts functional outcomes of surgery for deep endometriosis infiltrating the rectum: Results of the ENDORE randomized trial.
    Roman H; Bubenheim M; Huet E; Bridoux V; Zacharopoulou C; Collinet P; Daraï E; Tuech JJ
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):625-629. PubMed ID: 30902761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Methylnaltrexone for the treatment of opioid-induced constipation.
    Bader S; Dürk T; Becker G
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.